Two Sigma Securities’s Dare Bioscience DARE Stock Holding History

Two Sigma Securities’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,575	Closed	-$34.6K	–	3018
2024 Q2	$34.6K	Buy	8,575 +5,801	+209%	+$28.1K	﹤0.01%	2622
2024 Q1	$16.3K	Buy	+2,774	New	+$13.6K	﹤0.01%	2696
2023 Q4	–	Sell	-1,956	Closed	-$10.8K	–	3126
2023 Q3	$10.8K	Buy	+1,956	New	+$16.1K	﹤0.01%	2685
2022 Q1	–	Sell	-968	Closed	-$23K	–	2175
2021 Q4	$23K	Buy	+968	New	+$19.9K	﹤0.01%	1389
2021 Q3	–	Sell	-3,700	Closed	-$84K	–	1624
2021 Q2	$84K	Buy	+3,700	New	+$63.2K	﹤0.01%	1363
2019 Q2	–	Sell	-1,753	Closed	-$29K	–	2129
2019 Q1	$29K	Buy	+1,753	New	+$20.4K	﹤0.01%	1650
2018 Q2	–	Sell	-1,133	Closed	-$11K	–	2693
2018 Q1	$11K	Buy	+1,133	New	+$22.9K	﹤0.01%	2603

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Securities's DARE Position: Q3 2024 in Review

Two Sigma Securities sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 8,575 shares — an estimated $34.6K sold.

Two Sigma Securities first reported a position in DARE in Q1 2018 and held it in 7 quarters. The position peaked at $84K in Q2 2021. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

Two Sigma Securities reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 8,575 Dare Bioscience shares in Q3 2024, an estimated $34.6K.
Two Sigma Securities first reported a position in Dare Bioscience in Q1 2018 and held it in 7 quarters.
Two Sigma Securities's Dare Bioscience position peaked at $84K in Q2 2021.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.